Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT03161093 ×

NCT03161093

This funder is selected. Its supporting articles are shown below.

NCT031610931

Articles mentioning NCT03161093

1 articles · page 1 of 1

A phase III, randomised, double-blind, multi-dose, placebo- and naproxen-controlled study to evaluate the efficacy and safety of fasinumab in patients with pain due to osteoarthritis of the knee or hip

rmdopen · abstract · 2026-01-16 · 1 matching annotations

82.9%

NCT03161093 fasinumab naproxen OA

…hat previously observed for fasinumab.Trial registration number NCT03161093.…